Healthcare Holding Schweiz AG, a leading provider of services and distributor of medical technology in Switzerland, has expanded its portfolio with the acquisition of Ino ...

On the basis of these results, additional studies are needed to ascertain the optimal use of InO, in terms of dose, dosing frequency, and duration of treatment, both alone and in combination with ...

So our plans for our heterologous boost program are to continue to use. INO-4800. And we're holding INO-4802 in reserve and we're not planning to conduct studies the INO-4802 at this time.

Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia; INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial ...

Inovio Pharmaceuticals Inc (NASDAQ:INO) has resolved the manufacturing issue with the single-use array component of the Selectra device, which is crucial for their BLA submission for INO 3,107.

The latest price target for Inovio Pharmaceuticals (NASDAQ:INO) was reported by RBC Capital on May 14, 2025. The analyst firm set a price target for $5.00 expecting INO to rise to within 12 months ...

INO comes from good stock. The bijou modern Greek restaurant on Newburgh Street in London, just off Carnaby Street, was co-founded by businessman Andreas Labridis and chefs Georgianna Hiliadaki ...